Last reviewed · How we verify
AMG 570
At a glance
| Generic name | AMG 570 |
|---|---|
| Also known as | Active Comparator, Investigational Product, and Study drug |
| Sponsor | Amgen |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Efficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE) (PHASE2)
- Multiple Ascending Doses of Rozibafusp Alfa (AMG 570) in Adults With Rheumatoid Arthritis (PHASE1)
- Single Ascending Dose Study of AMG 570 in Healthy Subjects (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |